Exploring the venomous potential of marine crustaceans for drug development

Many animals use venoms for self-defense or hunting. The components of such venom, known as toxins, interfere with various physiological processes – which is also the reason why they are so interesting for the development of new pharmacological agents.

Galderma deprioritizes study for IL-31 drug; UCB stops work in rare encephalitis

Plus, news about GlycoMimetics and Indivior: Galderma stops plans to develop nemolizumab in Phase 2: The Swiss dermatology company said it … Sign up to

July 26, 2024

AKASA Unveils Gen AI Assistant, Cuts Prior Authorization Time by 50%

What You Should Know: – AKASA, a leader in generative AI (GenAI) solutions for the revenue cycle, today announced the launch of Authorization Advisor™. –

March 14, 2024

J&J to seek FDA approval after small-bore Impella heart pump hits trial goal

Dive Brief: Johnson & Johnson said Monday that a pivotal trial for the Impella ECP heart pump met its primary endpoint, positioning the company to seek

October 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.